Serum selenoprotein P in lean and obese Egyptian individuals and its relation to insulin resistance

References

• Fontenelle LC, Feitosa MM, Morais JB, et al. The role of selenium in insulin resistance. Braz J Pharm Sci. 2018;54(1). https://doi.org/10.1590/s2175-97902018000100139.
   Google Scholar
• Graae AS, Hollensted M, Kloppenborg JT, et al. An adult-based insulin resistance genetic risk score associates with insulin resistance, metabolic traits and altered fat distribution in danish children and adolescents who are overweight or obese. Diabetologia. 2018;61(8):1769–1779.
   Web of Science ®Google Scholar
• Bril F, Cusi K. Basic concepts in insulin resistance and diabetes treatment. In: Cohen Sabban E.,Puchulu F.,Cusi K. (eds). Dermatology and diabetes. Berlin: Springer; 2018. p. 19–35.
   Google Scholar
• Flisiak-Jackiewicz M, Bobrus-Chociej A, Wasilewska N, et al. Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children? Adv Med Sci. 2019;64(2):280–284. .
   Web of Science ®Google Scholar
• Saito Y. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. J Clin Biochem Nutr. 2020;66(1):1–7.
   PubMed Web of Science ®Google Scholar
• Di Giuseppe R, Koch M, Nöthlings U, et al. Metabolomics signature associated with circulating serum selenoprotein P levels. Endocrine. 2019;64(3):486–495. .
   Web of Science ®Google Scholar
• Ke Y, Xu C, Lin J, et al. Role of hepatokines in non-alcoholic fatty liver disease. J Transl Int Med. 2019;7(4):143–148. .
   Web of Science ®Google Scholar
• Thaker VV, Falkner B. Insulin Resistance and Other Mechanisms of Obesity Hypertension. In: Flynn J, Ingelfinger J, Redwine K, editors. Pediatric Hypertension. Springer, Cham; 2017;1–22
   Google Scholar
• Dilmen OK. Methods used to measure postoperative insulin resistance. Int Urol Nephrol. 2017;49(4):647.
   Web of Science ®Google Scholar
• Kyrou I, Panagiotakos DB, Kouli GM, et al. Lipid accumulation product in relation to 10-year cardiovascular disease incidence in caucasian adults: the ATTICA study. Atherosclerosis. 2018;279:10–16.
   Web of Science ®Google Scholar
• Gârgavu SR, Clenciu D, Roşu MM, et al. Visceral adiposity index (VAI) – a potential marker of cardiometabolic risk. Arch Balkan Medical Union. 2018;53(2):246–251. .
   Google Scholar
• Bo MS, Cheah WL, Lwin S, et al. Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an university in Malaysia. J Nutr Metab. 2018;2018:7027624.
   Web of Science ®Google Scholar
• Friedwald WT, Levy RL, Fredrickson DS. Estimation of the concentration of low density lipoprotein Cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499.
   Web of Science ®Google Scholar
• Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;10:1607.
   PubMed Web of Science ®Google Scholar
• Huang RL, Li CH, Du YF, et al. Discovery of a role of the novel hepatokine, hepassocin, in obesity. Biofactors. 2020 Jan;46(1):100–105.
   Web of Science ®Google Scholar
• Ennequin G, Sirvent P, Whitham M. Role of exercise-induced hepatokines in metabolic disorders. Am J Physiol Endocrinol Metab. 2019;317(1):E11–E24.
   Web of Science ®Google Scholar
• Chadani H, Usui S, Inoue O, et al. Endogenous selenoprotein P, a liver-derived secretory protein, mediates myocardial ischemia/reperfusion injury in mice. Int J Mol Sci. 2018 Mar 16;19(3). pii: E878.
   Web of Science ®Google Scholar
• Callo Quinte G, Barros F, Gigante DP, et al. Overweight trajectory and cardio metabolic risk factors in young adults. BMC Pediatr. 2019;19(1):75.
   Google Scholar
• Du T, Yu X, Zhang J, et al. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetol. 2015;52(5):855–863.
   Web of Science ®Google Scholar
• Chen M, Liu B, Wilkinson D, et al. Selenoprotein P is elevated in individuals with obesity, but is not independently associated with insulin resistance. Obes Res Clin Pract. 2017 Mar;11(2):227–232.
   Web of Science ®Google Scholar
• Shen SW, Lu Y, Li F, et al. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17(1):11.
   Google Scholar
• Szczygielska A, Widomska S, Jaraszkiewicz M, et al. Blood lipids profile in obese or overweight patients. Ann Univ Mariae Curie Sklodowska Med. 2003;58(2):343–349.
   Google Scholar
• Mazidi M, Gao HK, Kengne AP. Lipid accumulation product and visceral adiposity index are associated with dietary patterns in adult Americans. Medicine (Baltimore). 2018;97(19):0322.
   PubMed Web of Science ®Google Scholar
• Cardona-Alvarado MI, López-Moreno G, Aguilar H, et al. Relationship of visceral adiposity index with the metabolic phenotype and cardiovascular markers in non-diabetic subjects. Health Sci J. 2018;12(5):588.
   Google Scholar
• Choudhary MK, Eräranta A, Koskela J, et al. Atherogenic index of plasma is related to arterial stiffness but not to blood pressure in normotensive and never-treated hypertensive subjects. Blood Press. 2019;28(3):157–167. .
   PubMed Web of Science ®Google Scholar
• Pekgor S, Duran C, Berberoglu U, et al. The role of visceral adiposity index levels in predicting the presence of metabolic syndrome and insulin resistance in overweight and obese patients. Metab Syndr Relat Disord. 2019 Jun;17(5):296–302.
   Web of Science ®Google Scholar
• Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in indian population. Metab Syndr Relat Disord. 2018 Jun;16(5):240–245.
   Web of Science ®Google Scholar
• Tsutsumi R, Saito Y. Selenoprotein P; P for plasma, prognosis, prophylaxis, and more. Biol Pharm Bull. 2020;43(3):366–374.
   Web of Science ®Google Scholar
• Yang SJ, Hwang SY, Choi HY, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis. J Clin Endocrinol Metab. 2011;96(8):1325–1329.
   PubMed Web of Science ®Google Scholar